Evercore ISI initiated coverage on Humana (NYSE: HUM) with an In Line rating and a $295 price target, saying the company’s long-term growth potential was offset by near-term uncertainty. The firm said Humana, with a market cap of roughly$33 billion, was well-positioned to grow adjusted EBIT at a low double-digit rate and EPS at a mid-teens CAGR post-2028. However, it cautioned that the medium-term outlook was less clear as the company worked toward normalized margins. Evercore said management’s goal to rea ...